Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.28 is 10% below its 5-year average of 8.13, around the middle of its 5-year range (4.92–11.54).
As of the fiscal period ended Tuesday, June 30, 2026. 12.95% below its 12-month average of 8.37.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.28.
QUICK RATIO (ACID-TEST)
7.28
QUICK RATIO (ACID-TEST) AVG TTM
8.37
QUICK RATIO (ACID-TEST) AVG 3Y
7.60
QUICK RATIO (ACID-TEST) AVG 5Y
8.13
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-12.95%
CURRENT VS 3Y AVG
-4.11%
CURRENT VS 5Y AVG
-10.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+117.10%
vs the sector median at left
Black Diamond Therapeutics, Inc.
Market Cap
$103.14M
Quick Ratio (Acid-Test)
7.28
TTM Avg
8.37
3Y Avg
7.60
5Y Avg
8.13
Market Cap
$102.75M
Quick Ratio (Acid-Test)
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.37
Market Cap
$104.26M
Quick Ratio (Acid-Test)
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
Market Cap
$104.68M
Quick Ratio (Acid-Test)
13.53
TTM Avg
12.93
3Y Avg
9.36
5Y Avg
9.36
Market Cap
$101.36M
Quick Ratio (Acid-Test)
1.83
TTM Avg
1.56
3Y Avg
1.30
5Y Avg
1.30
Market Cap
$106.52M
Quick Ratio (Acid-Test)
5.05
TTM Avg
1.26
3Y Avg
3.46
5Y Avg
6.50
Market Cap
$99.62M
Quick Ratio (Acid-Test)
26.75
TTM Avg
10.50
3Y Avg
7.03
5Y Avg
10.82
Market Cap
$106.93M
Quick Ratio (Acid-Test)
3.25
TTM Avg
3.06
3Y Avg
4.28
5Y Avg
3.23
Market Cap
$106.96M
Quick Ratio (Acid-Test)
0.63
TTM Avg
0.47
3Y Avg
0.75
5Y Avg
1.22
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $103.14M | 7.28 | 8.37 | 7.60 | 8.13 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | 8.54 | 8.31 | 10.99 | 13.37 |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 1.86 | 1.97 | 2.28 | 2.24 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
| The Joint Corp. (JYNT)vs › | $101.36M | 1.83 | 1.56 | 1.30 | 1.30 |
| Immunic, Inc. (IMUX)vs › | $106.52M | 5.05 | 1.26 | 3.46 | 6.50 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | 26.75 | 10.50 | 7.03 | 10.82 |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | 3.25 | 3.06 | 4.28 | 3.23 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | 0.63 | 0.47 | 0.75 | 1.22 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | 0.96 | 0.94 | 1.06 | 1.28 |
Quick Ratio
7.28
Excludes inventory
Current Ratio
7.28
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.28 |
| 2026-03-31 | 8.46 |
| 2025-12-31 | 8.42 |
| 2025-09-30 | 8.94 |
| 2025-06-30 | 8.73 |
| 2025-03-31 | 9.24 |
| 2024-12-31 | 4.92 |
| 2024-09-30 | 5.55 |
| 2024-06-30 | 6.87 |
| 2024-03-31 | 7.05 |
| 2023-12-31 | 6.82 |
| 2023-09-30 | 9.76 |
| 2023-06-30 | 6.69 |
| 2023-03-31 | 8.40 |
| 2022-12-31 | 8.37 |
| 2022-09-30 | 7.14 |
| 2022-06-30 | 8.55 |
| 2022-03-31 | 9.67 |
| 2021-12-31 | 9.12 |
| 2021-09-30 | 9.16 |
| 2021-06-30 | 11.54 |
| 2021-03-31 | 15.90 |
| 2020-12-31 | 22.48 |
| 2020-09-30 | 29.66 |
| 2020-06-30 | 33.92 |
| 2020-03-31 | 49.60 |
| 2019-12-31 | 32.02 |
| 2019-09-30 | 16.99 |
| 2019-06-30 | 26.25 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 20.07 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
